Angiotensin-converting enzyme regulates bradykinin receptor gene expression

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 5 58-5, 2005, Pages

  Ignjacev Lazich, Ivana ^a   Kintsurashvili, Ekaterina ^a   Johns, Conrado ^a   Vitseva, Olga ^a   Duka, Ara ^a   Shenouda, Sherene ^a   Gavras, Irene ^a   Gavras, Haralambos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activator protein 1; Nuclear factor B; Peptidyl dipeptidase; Vascular smooth muscle cells

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CAPTOPRIL; CURCUMIN; DACTINOMYCIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONSENSUS SEQUENCE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RAT; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CYCLIC AMP; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; MALE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; RNA; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 27144469289     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00581.2005     Document Type: Article

References (34)

1. Aggarwal BB, Kumar A, and Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398, 2003.
2. Bull HG, Thornberry NA, and Cordes EH. Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography. J Biol Chem 260: 2963-2972, 1985.
3. Chabner BA, Ryan DP, Paz-Ares L, Garcia-Carbonero R, and Calabresi P. Antineoplastic agents In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, New York: McGraw Hill; 2001.
4. Corvol P, Williams TA, and Soubrier F. Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enzymol 248: 283-305, 1995.
5. Cushman DW and Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 20: 1637-1648, 1971.
6. Duka I, Kintsurashvili E, Gavras I, Johns C, Bresnahan M, and Gavras H. Vasoactive potential of the B(1) bradykinin receptor in normotension and hypertension. Circ Res 88: 275-281, 2001.
7. Duka I, Shenouda S, Johns C, Kintsurashvili E, Gavras I, and Gavras H. Role of the B(2) receptor of bradykinin in insulin sensitivity. Hypertension 38: 1355-1360, 2001.
8. Emanueli C, Angioni GR, Anania V, Spissu A, and Madeddu P. Blood pressure responses to acute or chronic captopril in mice with disruption of bradykinin B2-receptor gene. J Hypertens 15: 1701-1706, 1997.
9. Gavras H, Brunner HR, Laragh JH, Sealey JE, Gavras I, and Vukovich RA. An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med 291: 817-821, 1974.
10. Gavras H, Brunner HR, Turini GA, Kershaw GR, Tifft CP, Cuttelod S, Gavras I, Vukovich RA, and McKinstry DN. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N Engl J Med 298: 991-995, 1978.
11. Gavras H, Faxon DP, Berkoben J, Brunner HR, and Ryan TJ. Angiotensin converting enzyme inhibition in patients with congestive heart failure. Circulation 58: 770-775, 1978.
12. Ignjatovic T, Tan F, Brovkovych V, Skidgel RA, and Erdos EG. Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin Bl receptor. J Biol Chem 111: 16847-16852, 2002.
13. Kang G, Kong P, Yuh Y, Lim S, Yim S, Chun W, and Kim S. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor-kappaB bindings in BV2 microglial cells. J Pharm Sci 94: 325-328, 2004.
14. Kintsurashvili E, Duka I, Gavras I, Johns C, Farmakiotis D, and Gavras H. Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 281: H1778-H1783, 2001.
15. Kohlman OJr Neves Fde A, Ginoza M, Tavares A, Cezaretti ML, Zanella MT, Ribeiro AB, Gavras I, and Gavras H. Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinemia. Hypertension 25: 1003-1007, 1995.
16. Kondoh G, Tojo H, Nakatani Y, Komazawa N, Murata C, Yamagata K, Maeda Y, Kinoshita T, Okabe M, Taguchi R, and Takeda J. Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization. Nat Med 11: 160-166, 2005.
17. Madeddu P, Varoni MV, Palomba D, Emanueli C, Demontis MP, Glorioso N, Dessi-Fulgheri P, Sarzani R, and Anania V. Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 96: 3570-3578, 1997.
18. Marceau F, Hess JF, and Bachvarov DR. The B1 receptors for kinins. Pharmacol Rev 50: 357-386, 1998.
19. Meng QC and Oparil S. Purification and assay methods for angiotensin-converting enzyme. J Chromatogr A 743: 105-122, 1996.
20. Natesh R, Schwager SL, Sturrock ED, and Acharya KR. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421: 551-554, 2003.
21. Ni A, Chao L, and Chao J. Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation. J Biol Chem 273: 2784-2791, 1998.
22. Oppong SY and Hooper NM. Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane. Biochem J 292: 597-603, 1993.
23. Pesquero JB, Lindsey CJ, Paiva ACM, Ganten D, and Bader M. Transcriptional regulatory elements in the rat bradykinin B2 receptor gene. Immunopharmacology 33: 36-41, 1996.
24. Phagoo SB, Yaqoob M, Herrera-Martinez E, McIntyre P, Jones C, and Burgess GM. Regulation of bradykinin receptor gene expression in human lung fibroblasts. Eur J Pharmacol 397: 237-246, 2000.
25. Prado GN, Taylor L, Zhou X, Ricupero D, Mierke DF, and Polgar P. Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol 193: 275-286, 2002.
26. Regoli D and Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 32: 1-46, 1980.
27. Rhaleb NE, Peng H, Harding P, Tayeh M, LaPointe MC, and Carretero OA. Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts. Hypertension 37: 827-832, 2001.
28. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50: 172-186, 1971.
29. Ruiz-Ortega M, Lorenzo O, Ruperez M, Suzuki Y, and Egido J. Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Nephrol Dial Transplant 16, Suppl 1: 27-33, 2001.
30. Schanstra JP, Bataille E, Castano MEM, Barascud Y, Hirtz C, Pesquero JB, Pecher C, Gauthier F, Girolami J, and Bascands J. The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. J Clin Invest 101: 2080-2091, 1998.
31. Schmidlin F, Scherrer D, Daeffler L, Bertrand C, Landry Y, and Gies J. Interleukin-1beta induces bradykinin B2 receptor gene expression through a prostanoid cyclic AMP-dependent pathway in human bronchial smooth muscle cells. Mol Pharmacol 53: 1009-1015, 1998.
32. Skidgel RA and Erdos EG. Cellular carboxypeptidases. Immunol Rev 161: 129-141, 1998.
33. Yang HY, Erdos EG, and Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 214: 374-376, 1970.
34. Yang X, Taylor L, and Polgar P. Mechanisms in the transcriptional regulation of bradykinin B1 receptor gene expression. Identification of a minimum cell-type specific enhancer. J Biol Chem 273: 10763-10770, 1998.